BioRestorative Therapies, Inc. (BRTX)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
Dec 19, 16:00
1.20
+0.05
(+4.35%)
After-Hours: 20:00
BioRestorative Therapies EPS Diluted (Quarterly): -0.3333 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adaptive Biotechnologies Corp. | 0.0585 |
| The Oncology Institute, Inc. | -0.1413 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.038M |
| Revenue (Quarterly) | 0.0118M |
| Total Expenses (Quarterly) | 3.050M |
| Enterprise Value | 5.732M |
| Gross Profit Margin (Quarterly) | -435.6% |
| Profit Margin (Quarterly) | -25.75K% |
| Earnings Yield | -131.5% |
| Normalized Earnings Yield | -143.22 |